The efficacy of the substitution of Carnivit in patients with chronic failure treated with hemodialysis;Ocena skutecznosci substytucyjnego stosowania preparatu Carnivit u chorych na przewlekla niewydolnosc nerek leczonych hemodializa

Polskie Archiwum Medycyny Wewnetrznej

Volumn 102, Issue 4, 1999, Pages 885-891

  Wanic Kossowska, Maria ^a   Piszczek, Irena ^b   Rogacka, Dorota ^c   Czarnecki, Ryszard ^a   Koziol, Lidia ^a   Czekalski, Stanisław ^a  

^a Klinika Nefrologii Instytutu C   (Poland)

^b Szpital MSW w Poznaniu   (Poland)

^c Klinika Intensywnej Terapii K   (Poland)

Author keywords

Chronic renal failure; Hemodialysis; L carnitine

Indexed keywords

CARNITINE; CARNIVIT;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; FEMALE; HEART PERFORMANCE; HEMODIALYSIS; HUMAN; MALE; TREATMENT OUTCOME; BLOOD; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; METHODOLOGY; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

ADULT; AGED; CARNITINE; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 0033206021     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Fagher B., Thysell H., Nilsson-Ehle P., Monti M. i wsp.: The effect of D,L-camitine supplementation on muscle metabolism, neuropathy, cardiac and hepatic function in hemodialysis patients. Acta Med. Scand., 1982, 52, 295.
2. Rumpf K.W., Leschke M., Eisenhauer T., Becker K.: Quantitative assessement of caraitine loss during haemodialysis and hemofiltration. Proc. Cur. Dial. Transplant. Ass., 1982, 19, 298.
3. Wanner C., Horl W.H.: Carnitine abnormalities in patients with renal insufficiency. Nephron, 1988, 50, 89.
4. Rogerson M.E., Rylance P.B., Wilson R., De Sousa C.: Carnitine and weakness in hemodialysis patients. Nephrol. Dial. Transplant., 1989, 4, 366.
5. Giovenali P., Fennocchio D., Montanari G., Cancellotti C. i wsp.: Selective trophic effect of L-carnitine in typ I and II a skeletal muscle fibers. Kidney Int., 1994, 46, 1616.
6. Deverenx r.b., Alonso D.R., Lutas E.M. i wsp.: Echocardiographic assessement of left ventricular hypertophy: comparison to necropsy findings. Am. J. Cardiol., 1986, 57, 450.
7. Armitage P.: Melody statystyczne w badaniach medycznych. PZWL, Warszawa 1978.
8. Łysiak-Szydłowska W.: Fizjologiczna rola L-karnityny w organizmie człowieka - przyczyny i skutki jej niedoboru. Pol. Tyg. Lek., 1988, 10, 337.
9. Wanic-Kossowska M.: Miopatia mocznicowa. Analiza wybranych przyczyn i sposobów jej zapobiegania. Praca habilitacyjna, Poznań, 1997.
10. Siami G., Clinton M.E., Mrak R., Griffis J. i wsp.: Evaluation of the effect of intravenous L-carnitine therapy on function, structure and fatty acid metabolism of skeletal muscle in patients receiving chronic hemodialysis. Nephron, 1991, 57, 306.
11. Spagnoli L.G., Palmieri G., Mauriello A., Vacha G.M.: Morphometric evidence of the trophic effect of L-carnitine on human skeletal muscle. Nephron, 1990, 55, 16.
12. Angelini C. et al: Use of carnitine in exercise physiology. Adv. Clin. Enzymol., 1986, IV, 103.
13. Massie B.M., Simonini A., Saghal P., Wells L.: Relation of systemic and local muscle exercise capacity to skeletal muscle characteristic in men with congestive heart failure. J. Am. Coll. Cardiol., 1996, 27, 140.
14. Ahmad S., Robertson H.T., Golper T.A., Wolfson M. i wsp.: Muliticenter trial of L-carnitine in maintenance hemodialysis patients. II Clinical and biochemical effects. Kidney Int., 1990, 38, 5, 912.
15. Cooper R.S., Simmons B.E., Castaner A. i wsp.: Left ventricular hypertrophy is associated with worse survival independent of ventricular function and number of coronary arteries severely narrowed. Am. J. Cardiol., 1990, 65, 441.
16. Levy D., Anderson K.M., Savage D.D. i wsp.: Echocardiographic determined left ventricular hypertrophy prevalance and risk factors. The Framingham Heart Study. Ann. Intern. Med., 1988, 108, 7.
17. Levy D., Garrison R.J., Savage D.D. i wsp.: left ventricular mass and incidence of coronary artery disease in elderly cohort. Ann. Intern. Med., 1989, 110, 101.
18. Byrd B.F., Wahr D., Yin Shi Wang i wsp.: Left ventricular mass and volume mass ratio determined by two-dimensional echocardiography in normal adults. J. Am. Coll. Cardiol., 1985, 6, 1021.
19. Grossman W., Mc Laurin L.P.: Diastolic properties of the left ventricle. Ann. Intern. Med., 1976, 84, 316.
20. Hanrath P., Mathey D.G., Siegert R. i wsp.: Left ventricular relaxation and filling pattern in different forms of left ventricular hypertrophy an echocardiographic study. Am. J. Cardiol., 1980, 45, 15.
21. Lorell B.H., Grossman W.: Cardiac hypertrophy: the consequences for diastole. J. Am. Coll. Cardiol., 1987, 9, 1189.
22. Ishida Y., Meissner J.S., Tsujika K. i wsp.: Left ventricular filling dynamic influence of left ventricular relaxation and left ventricular pressure. Circulation, 1986, 74, 187.
23. Kowey P.R., Friehling T.D., Sewter J. i wsp.: Electrophysiological effects of left ventricular hypertrophy. Circulation, 1991, 83, 1067.
24. Huting J., Alpert M.A.: Course of left ventricular diasstolic dysfunction in end-stage renal disease on long-term continuous ambulatory peritoneal dialysis. Clin. Nephrol., 1993, 39, 2, 81.
25. Bartels et al: Effects of L-propionylcarnitine on ischemia-induced myocardial dysfunction in men with angina pectoris. Am. J. Cardiol., 1994, 2 (74), 125.